• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路手术后再入院风险分析:制定降低再入院率的策略。

Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions.

机构信息

Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY, USA.

出版信息

J Am Coll Surg. 2013 Mar;216(3):412-9. doi: 10.1016/j.jamcollsurg.2012.11.009. Epub 2013 Jan 11.

DOI:10.1016/j.jamcollsurg.2012.11.009
PMID:23313544
Abstract

BACKGROUND

Readmission within 30 days of adult cardiac surgery procedures is a frequent contributor to the costs of cardiac surgery hospitalizations, but current data regarding risk factors for readmission are limited. We therefore sought to analyze quality improvement risk factors for readmissions after coronary bypass surgery (CABG).

STUDY DESIGN

The records of patients undergoing CABG at our institution from July 2006 to June 2011 were evaluated for variables with potential literature-based associations with readmission, including New York Cardiac Surgery Reporting System (CSRS) risk factors, discharge medications, and laboratory values.

RESULTS

The readmission rate was 13% (n = 158 of 1,205); the CSRS predicted rate was 8.7% (observed/expected ratio = 1.5). Median time from CABG discharge to readmission was 6 days (interquartile range [IQ] 3 to 13 days). Median readmission length of stay was 4 days (IQ 2 to 7 days). The most frequent reasons for readmission were cardiac (n = 40 [25% of readmissions]) and pulmonary complications, including pleural effusions (n = 36 [23%]). Beyond CSRS risk factors, only abnormal discharge serum creatinine was associated with increased readmission (p = 0.05). Combining CSRS risk variables for government insurance and unplanned reoperation led to the highest readmission risk (odds ratio [OR] 5.7, 95% CI 1.7 to 18.7).

CONCLUSIONS

Coronary bypass surgery readmissions remain a persistent clinical challenge. Given that readmissions often occur within the first week postdischarge and are typically of short duration, post-CABG readmissions may be reduced through careful postoperative surveillance for readmission risk factors (eg, abnormal serum creatinine or unplanned reoperations) and/or for frequent causes of readmission (eg, pleural effusions).

摘要

背景

成人心脏手术后 30 天内再入院是导致心脏手术住院费用增加的一个常见因素,但目前关于再入院风险因素的数据有限。因此,我们试图分析冠状动脉旁路移植术(CABG)后再入院的质量改进风险因素。

研究设计

对我院 2006 年 7 月至 2011 年 6 月期间接受 CABG 的患者的记录进行了评估,评估了与再入院有潜在文献关联的变量,包括纽约心脏手术报告系统(CSRS)风险因素、出院药物和实验室值。

结果

再入院率为 13%(n=158/1205);CSRS 预测率为 8.7%(观察/预期比=1.5)。从 CABG 出院到再入院的中位时间为 6 天(四分位间距[IQ]3 至 13 天)。中位再入院住院时间为 4 天(IQ2 至 7 天)。再入院的最常见原因是心脏(n=40[25%的再入院])和肺部并发症,包括胸腔积液(n=36[23%])。除 CSRS 风险因素外,只有异常的出院血清肌酐与再入院风险增加相关(p=0.05)。将政府保险和非计划性再次手术的 CSRS 风险变量结合起来,导致再入院风险最高(比值比[OR]5.7,95%置信区间[CI]1.7 至 18.7)。

结论

冠状动脉旁路移植术再入院仍然是一个持续存在的临床挑战。鉴于再入院通常发生在出院后第一周内,且持续时间通常较短,通过仔细监测再入院风险因素(如血清肌酐异常或非计划性再次手术)和/或再入院的常见原因(如胸腔积液),可以减少 CABG 后的再入院。

相似文献

1
Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions.冠状动脉旁路手术后再入院风险分析:制定降低再入院率的策略。
J Am Coll Surg. 2013 Mar;216(3):412-9. doi: 10.1016/j.jamcollsurg.2012.11.009. Epub 2013 Jan 11.
2
Hospital variation in readmission after coronary artery bypass surgery in California.加利福尼亚州冠状动脉搭桥手术后再入院情况的医院差异。
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):729-37. doi: 10.1161/CIRCOUTCOMES.112.966945. Epub 2012 Sep 4.
3
30-day readmissions after coronary artery bypass graft surgery in New York State.纽约州冠状动脉旁路移植手术后 30 天再入院情况。
JACC Cardiovasc Interv. 2011 May;4(5):569-76. doi: 10.1016/j.jcin.2011.01.010.
4
Risk factors associated with readmission after pediatric cardiothoracic surgery.儿科心胸外科术后再入院的相关风险因素。
Ann Thorac Surg. 2012 Sep;94(3):865-73. doi: 10.1016/j.athoracsur.2012.04.025. Epub 2012 Jun 8.
5
Predictors of readmission for complications of coronary artery bypass graft surgery.冠状动脉搭桥手术并发症再入院的预测因素。
JAMA. 2003 Aug 13;290(6):773-80. doi: 10.1001/jama.290.6.773.
6
Uniform standards do not apply to readmission following coronary artery bypass surgery: a multi-institutional study.统一标准不适用于冠状动脉搭桥手术后的再入院治疗:一项多机构研究。
J Thorac Cardiovasc Surg. 2015 Mar;149(3):850-7.e1; discussion 857. doi: 10.1016/j.jtcvs.2014.08.059. Epub 2014 Sep 16.
7
Does anemia impact hospital readmissions after coronary artery bypass surgery?贫血是否会影响冠状动脉旁路手术后的住院再入院率?
Transfusion. 2013 Aug;53(8):1688-97; quiz 1687. doi: 10.1111/trf.12007. Epub 2012 Dec 11.
8
An analysis of causes of readmission after spine surgery.脊柱手术后再入院原因分析。
Spine (Phila Pa 1976). 2012 Jun 15;37(14):1260-6. doi: 10.1097/BRS.0b013e318245f561.
9
Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass.Roux-en-Y胃旁路术后90天内的再入院和再次手术模式。
Surg Obes Relat Dis. 2009 Jul-Aug;5(4):416-23. doi: 10.1016/j.soard.2009.01.008. Epub 2009 Jan 31.
10
Hospital readmission after noncardiac surgery: the role of major complications.非心脏手术后的再次住院:主要并发症的作用。
JAMA Surg. 2014 May;149(5):439-45. doi: 10.1001/jamasurg.2014.4.

引用本文的文献

1
Opportunities and Barriers in Telerehabilitation for Coronary Bypass Patients: A Case Study from the Faroe Islands.冠状动脉搭桥患者远程康复的机遇与障碍:来自法罗群岛的案例研究
Telemed Rep. 2025 Jul 24;6(1):185-194. doi: 10.1177/26924366251362187. eCollection 2025.
2
Construction and evaluation of a 180-day readmission prediction model for chronic heart failure patients based on sCD40L.基于可溶性CD40配体的慢性心力衰竭患者180天再入院预测模型的构建与评估
Medicine (Baltimore). 2025 Apr 11;104(15):e42134. doi: 10.1097/MD.0000000000042134.
3
Derivation and validation of predictive indices for cardiac readmission after coronary and valvular surgery - A multicenter study.
冠状动脉和心脏瓣膜手术后心脏再入院预测指标的推导与验证——一项多中心研究
Am Heart J Plus. 2023 Mar 3;28:100285. doi: 10.1016/j.ahjo.2023.100285. eCollection 2023 Apr.
4
Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery.新型抗血栓药物清除系统降低术前使用替格瑞洛行心脏手术患者出血风险的成本效果和预算影响。
Am J Cardiovasc Drugs. 2023 Jul;23(4):429-440. doi: 10.1007/s40256-023-00587-4. Epub 2023 May 19.
5
Development and validation of an interpretable machine learning scoring tool for estimating time to emergency readmissions.用于估计急诊再入院时间的可解释机器学习评分工具的开发与验证
EClinicalMedicine. 2022 Mar 6;45:101315. doi: 10.1016/j.eclinm.2022.101315. eCollection 2022 Mar.
6
Update: Gender differences in CABG outcomes-Have we bridged the gap?更新:冠状动脉旁路移植术(CABG)结局中的性别差异——我们是否已经弥合了差距?
PLoS One. 2021 Sep 15;16(9):e0255170. doi: 10.1371/journal.pone.0255170. eCollection 2021.
7
Patient and hospital factors associated with 30-day readmissions after coronary artery bypass graft (CABG) surgery: a systematic review and meta-analysis.与冠状动脉旁路移植术(CABG)后 30 天再入院相关的患者和医院因素:系统评价和荟萃分析。
J Cardiothorac Surg. 2021 Jun 10;16(1):172. doi: 10.1186/s13019-021-01556-1.
8
Thirty-day readmission rates and associated risk factors after coronary artery bypass grafting.冠状动脉搭桥术后30天再入院率及相关危险因素。
J Taibah Univ Med Sci. 2020 Jun 26;15(4):292-297. doi: 10.1016/j.jtumed.2020.05.004. eCollection 2020 Aug.
9
Post-acute care referral in United States of America: a multiregional study of factors associated with referral destination in a cohort of patients with coronary artery bypass graft or valve replacement.美国的急性后期医疗转介:一项多地区研究,分析了与冠状动脉旁路移植或瓣膜置换术后患者转介去向相关的因素。
BMC Med Inform Decis Mak. 2019 Nov 14;19(1):223. doi: 10.1186/s12911-019-0955-0.
10
Predicted Risk of Mortality Score predicts 30-day readmission after coronary artery bypass grafting.死亡风险预测评分可预测冠状动脉搭桥术后30天再入院情况。
Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):661-668. doi: 10.1007/s11748-019-01079-6. Epub 2019 Feb 8.